Market Overview

12 Biggest Mid-Day Losers For Thursday



  • Aradigm Corporation (NASDAQ: ARDM) shares dropped 57.1 percent to $2.25. Aradigm disclosed that it has met primary and secondary endpoint in ORBIT-4. However, it missed ORBIT-3 primary and secondary endpoint.
  • Heat Biologics Inc (NASDAQ: HTBX) shares tumbled 55.9 percent to $1.27 following a negative outcome of its bladder cancer study. Heat Biologics said its phase 2 trial of Vesigenurtacel-L (HS-410) in combination with BCG in patients with non-muscle invasive bladder cancer (NMIBC) failed to meet primary endpoint.
  • Palatin Technologies, Inc. (NYSE: PTN) declined 29.7 percent to $0.570. Palatin Technologies priced 25.38 million shares for $16.5 million in gross proceeds.
  • Express, Inc. (NYSE: EXPR) dropped 21.9 percent to $10.44 after the company issued a weak outlook for the fourth quarter.
  • Bazaarvoice Inc (NASDAQ: BV) shares declined 13.7 percent to $4.57. Bazaarvoice reported Q2 earnings of $0.02 per share on revenue of $50.4 million.
  • FuelCell Energy Inc (NASDAQ: FCEL) dropped 13.3 percent to $1.95 after the company announced plans to cut 17 percent of its workforce. The company also issued a weak sales forecast for the fourth quarter.
  • Forward Pharma A/S (NASDAQ: FWP) shares declined 11.6 percent to $19.56. Forward Pharma shares have increased 1.65 percent over the past 52 weeks, while the S&P 500 index has gained 4.57 percent in the same period.
  • Guess?, Inc. (NYSE: GES) shares fell 11.2 percent to $13.60 as the company reported weaker-than-expected earnings for its third quarter on Wednesday.
  • Dollar General Corp. (NYSE: DG) shares dropped 8 percent to $71.16 after the company posted downbeat Q3 earnings.
  • Xencor Inc (NASDAQ: XNCR) shares fell 4.3 percent to $24.45. Xencor priced its 4.585 million offering at $24 per share.
  • Cerner Corporation (NASDAQ: CERN) declined 3.7 percent to $47.92. Leerink Swann downgraded Cerner from Outperform to Market Perform.
  • Quintiles IMS Holdings Inc (NYSE: Q) shares dropped 3.3 percent to $74.33. Raymond James downgraded Quintiles IMS from Strong Buy to Market Perform.

Posted-In: Mid-Day LosersNews Movers & Shakers Intraday Update Markets


Related Articles (ARDM + BV)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

The Right Ways To Play A Rebound With China ETFs

The '$5 Threshold' Trading Strategy Explained